Scholarship: Fully funded
Degree: PhD or MD/PhD
Nationality: International Students
Application deadlines: Open
Current research in our lab focuses on studying how genetic and epigenetic regulation of cancer cells and cancer stem cells can shape the immunosuppressive tumor microenvironment, and reciprocally, how these infiltrating immune cells affect tumor progression and the effectiveness of immunotherapies. For more information on research projects in the lab, please refer to following recent publications (Cancer Cell 2019; Cancer Discovery 2020, cover; PNAS 2017; Cell Rep2021; Trends in Immunology, 2021, cover; Trends in Cell Biology, 2021, cover; Trends Pharmacol Sci2022; Trends in Cancer 2022, cover; Cancer Immunology Research 2022; Journal of Clinical Investigation 2023; Cell Reports accepted) and our webpage: https://sites.northwestern.edu/chenlab/.
Northwestern is committed to creating a diverse and inclusive workplace where all employees have the opportunity to succeed and thrive.
We are proud to be an Equal Opportunity, Affirmative Action Employer of all protected classes, including veterans and individuals with disabilities. This means that we actively seek out and encourage applicants from underrepresented groups, such as women, underrepresented racial and ethnic minorities, individuals with disabilities, and veterans, to join our team.
- Cancer biology, tumor immunology and cancer genetics/epigenetics.
- Experience in cancer biology, tumor immunology and cancer genetics/epigenetics is preferred.
- Preference will be given to candidates with first-author publications in peer-reviewed journals.
Interested applicants please send your curriculum vitae, cover letter, and names and contact information of three references to Dr. Chen at [email protected]